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Researcher Opinions on Human Embryonic Stem Cell Issues
To the Editor:
The potential of stem cell therapy, and its ethical implica-
tions have generated vibrant debate (Hochedlinger and
Jaenisch, 2003; Lo et al, 2003; Vogel, 2003). Disagreement
among researchers and government representatives even
surrounds the number of existent human embryonic cell
lines. The current US Administration has estimated the
number of viable and robust human embryonic cell lines at
more than 60, whereas the National Institute of Health’s
stem cell registry lists only 11 (Hall, 2003; NIH, 2003).
To assay researcher opinions on these matters, we dist-
ributed an anonymous, one-page, self-administered question-
naire at a recent small conference on stem cell research
(Montagna Symposium, 20031). Survey data were entered
twice by two different investigators and any differences were
reconciled. Statistical analysis was performed using SAS
Version 8 (Cary, North Carolina). This study was approved by
the Colorado Multiple Institutional Review Board in 2003. The
overall participant response rate was 56% (28/51), and 64% of
the respondents reported that they conducted stem cell
research (18/28). Fifty-four percent of the respondents were
male and the mean age was 36 y (standard deviation¼ 8).
Forty-six percent were academic faculty, scientists, or principal
investigators, 21% were graduate students or postdoctoral
fellows, and 18% were laboratory personnel.
Respondent opinions were as follows: 71% disagreed
that there is a sufficient amount of human embryonic stem
cell lines for research. The majority (54%) also disagreed that
adult stem cell and umbilical cord blood research are
comparable alternatives to human embryonic stem cell
research. The majority (60%) agreed that US policies have
hindered research, and only 7% agreed that the US govern-
ment is disseminating accurate information to the public
regarding human embryonic stem cell research and devel-
opment. Responses from the subset of respondents
identifying themselves as stem cell researchers did not differ
significantly from the responses of all respondents (Table I).
Table I. Stem cell researchers’ beliefs about human embryonic stem cell cines (n¼ 18)b
Number responding (% of all respondents)
Beliefs
Strongly
agree Agree
Not sure/
neutral Disagree
Strongly
disagree No answer
Sufficient number of human embryonic
stem cell lines exist
0 (0%) 1 (6%) 2 (11%) 8 (44%) 6 (33%) 1 (6%)
US government should limit the number
of human embryonic stem cell lines
developed
0 (0%) 2 (11%) 4 (22%) 6 (33%) 5 (28%) 1 (6%)
US government is disseminating
accurate information regarding human
embryonic stem cell research and
development
0 (0%) 1 (6%) 8 (44%) 4 (22%) 4 (22%) 1 (6%)
US government policies on human
embryonic stem cell research have
hindered research
4 (22%) 5 (28%) 6 (33%) 0 (0%) 1 (6%) 2 (11%)
Adult stem cell and umbilical cord
blood research are comparable alterna-
tives to human embryonic stem cell
research
1 (6%) 0 (0%) 4 (22%) 6 (33%) 6 (33%) 1 (6%)
Adequate funding for human embryonic
stem cell researcha
0 (0%) 3 (17%) 5 (28%) 6 (33%) 3 (17%) 1 (6%)
Have ethical concerns regarding human
embryonic stem cell researcha
2 (11%) 5 (28%) 1 (6%) 3 (17%) 4 (22%) 3 (17%)
aTotals do not add up to 100% due to rounding error.
bOriginal questionnaire available via e-mail from corresponding author.
1Montagna Symposium: 52nd Annual Montagna Symposium on
the Biology of Skin, ‘‘Stem Cells in Skin,’’ Snowmass, Colorado,
June 13–16, 2003.
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Estimates of the number of existent viable human
embryonic stem cell lines ranged from 4 to 80. Researchers’
estimates of the number of viable human embryonic stem
cell lines needed to sufficiently conduct research ranged
from 9 to an unlimited number.
The results from this survey confirm a considerable array
of opinion on human embryonic stem cell issues among re-
searchers and call for further investigation of the accuracy of
currently disseminated government information on the topic.
Amanda L. Drake,2 Lauren F. Heilig,2 Katarzyna Z. Kozak,
Eric J. Hester, and Robert P. Dellavallew
Dermatoepidemiology Research Unit, Department of Dermatology,
University of Colorado Health Sciences Center, Denver, Colorado,
USA; wDenver Veterans Affairs Medical Center, Denver, Colorado, USA
Work was performed in Denver, CO USA.
R.P.D. and E.J.H. were supported by the National Institute of Health
(grants K07 CA92550 and T32 AR7411).
DOI: 10.1111/j.0022-202X.2004.22343.x
Manuscript received September 10, 2003; accepted for publication
September 29, 2003
Address correspondence to: Robert Dellavalle, MD, PhD, Director,
Dermatoepidemiology Research Unit, University of Colorado Health
Sciences Center, 4200 E. 9th Ave., B-153, Denver, CO 80262, USA.
Email: Robert.Dellavalle@uchsc.edu
References
Hall SS: Bush’s Political Science. New York Times A35 June12, 2003
Hochedlinger K, Jaenisch R: Mechanisms of disease: Nuclear transplantation,
embryonic stem cell, and the potential for cell therapy. N Engl J Med
349:275–286, 2003
Lo B, Chou V, Cedars MI, et al: Consent from donors for embryo and stem cell
research. Science 301:921, 2003
NIH: Information on Eligibility Criteria for Federal Funding of Research on Human
Embryonic Stem Cells: NIH Human Embryonic Stem Cell Registry.
Available at http://stemcells.nih.gov/registry/. Accessed August 20, 2003
Vogel G: At odds again over stem cells. Science 301:289, 2003
2These authors contributed equally to this work.
856 LETTER TO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
